Experimental Induction of AGEs in Fetal L132 Lung Cells Changes the Level of Intracellular Cathepsin D
- 22 July 1999
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 261 (1) , 175-182
- https://doi.org/10.1006/bbrc.1999.0902
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Advanced glycation end products in neurodegeneration: More than early markers of oxidative stress?Annals of Neurology, 1998
- Constitutive nitric oxide synthase expression in retinal vascular endothelial cells is suppressed by high glucose and advanced glycation end products.Diabetes, 1998
- Diabetes, advanced glycation endproducts and vascular diseaseVascular Medicine, 1998
- Increased Pentosidine, an Advanced Glycation End Product, in Plasma and Synovial Fluid from Patients with Rheumatoid Arthritis and Its Relation with Inflammatory MarkersBiochemical and Biophysical Research Communications, 1998
- AGEs and their interaction with AGE-receptors in vascular disease and diabetes mellitus. I. The AGE conceptPublished by Oxford University Press (OUP) ,1998
- The influence of advanced glycation endproducts (AGE) on the expression of human endothelial adhesion moleculesExperimental and Clinical Endocrinology & Diabetes, 1998
- The serum concentration of the advanced glycation end-product N -(carboxymethyl)lysine is increased in uremia: Technical NoteKidney International, 1997
- Advanced glycation endproducts in ageing and Alzheimer's diseaseBrain Research Reviews, 1997
- Changes in biomechanical properties, composition of collagen and elastin, and advanced glycation endproducts of the rat aorta in relation to ageAtherosclerosis, 1996
- Advanced glycation end products contribute to amyloidosis in Alzheimer disease.Proceedings of the National Academy of Sciences, 1994